Date Filed | Type | Description |
07/18/2023 |
4
| Kerr Douglas (CHIEF MEDICAL OFFICER) has filed a Form 4 on Generation Bio Co.
Txns:
| Paid exercise price by delivering 2,183 shares
@ $5.08, valued at
$11.1k
Exercised 7,437 restricted stock units
@ $0 |
|
04/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/24/2023 |
4
| Kerr Douglas (CHIEF MEDICAL OFFICER) has filed a Form 4 on Generation Bio Co.
Txns:
| Granted 53,550 options to buy
@ $4.71, valued at
$252.2k
Granted 26,775 restricted stock units
@ $0 |
|
01/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/19/2022 |
4
| Kerr Douglas (CHIEF MEDICAL OFFICER) has filed a Form 4 on Generation Bio Co.
Txns:
| Paid exercise price by delivering 4,367 shares
@ $7.18, valued at
$31.4k
Exercised 14,876 restricted stock units
@ $0 |
|
01/25/2022 |
4
| Kerr Douglas (CHIEF MEDICAL OFFICER) has filed a Form 4 on Generation Bio Co.
Txns:
| Granted 119,000 options to buy
@ $6.49, valued at
$772.3k
Granted 59,500 restricted stock units
@ $0 |
|
07/12/2021 |
4
| Kerr Douglas (CHIEF MEDICAL OFFICER) has filed a Form 4 on Generation Bio Co.
Txns:
| Sold 1,629 shares
@ $24.99, valued at
$40.7k
Sold 1,889 shares
@ $25.39, valued at
$48k
Exercised 3,518 options to buy
@ $5.16, valued at
$18.2k
|
|
04/07/2021 |
4
| Kerr Douglas (CHIEF MEDICAL OFFICER) has filed a Form 4 on Generation Bio Co.
Txns:
| Sold 10,751 shares
@ $29.91, valued at
$321.6k
Sold 3,321 shares
@ $30.68, valued at
$101.9k
Exercised 14,072 options to buy
@ $5.16, valued at
$72.6k
|
|
03/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/11/2020 |
3
| Kerr Douglas (Chief Development Officer) has filed a Form 3 on Generation Bio Co. |